Eating spicy foods regularly may extend lifespan
the ONA take:
Eating spicy foods regularly may lower the risk of death from cancer, ischemic disease, and respiratory disease, according to a new observational study published in The BMJ.
For the study, researchers in China analyzed data from a prospective cohort study that included 487,375 adults from various various in China. All participants were between ages 30 and 70 and completed questionnaires about their health and consumption of red meat, vegetables, alcohol, and spicy foods. Participants were followed for an average of 7.2 years.
Results showed that consumption of spicy food 3 to 7 days a week was associated with a 14% reduced risk of death during the follow-up period compared with participants who consumed spicy foods less than once a week. Eating spicy foods once or twice a week was linked with a 10% reduced risk of death compared with those who ate it less than once a week.
Researchers also found that frequent consumption of spicy foods was associated with a reduced risk of death from cancer, ischemic heart disease, and respiratory diseases. This effect was more strongly observed in women than men.
Eating spicy foods regularly may lower the risk of death from cancer, ischemic disease, and respiratory disease.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
- Urine Drug Testing Policy Can Assist Opioid Treatment Decisions
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|